Go Back   Science Forums Biology Forum Molecular Biology Forum Physics Chemistry Forum > General Science Forums > Biology Forum
Register Search Today's Posts Mark Forums Read

Biology Forum Biology Forums. Ask questions and discuss the study of Biology. If you have Biology questions from your homework ask them here!


statins reduce the risk of heart transplant patients with tumors

statins reduce the risk of heart transplant patients with tumors - Biology Forum

statins reduce the risk of heart transplant patients with tumors - Biology Forums. Ask questions and discuss the study of Biology. If you have Biology questions from your homework ask them here!


Reply
 
LinkBack Thread Tools Display Modes
  #1  
Old 05-31-2012, 03:50 AM
UnSubscribed Vendor Advertiser
Points: 466, Level: 9 Points: 466, Level: 9 Points: 466, Level: 9
Activity: 0% Activity: 0% Activity: 0%
 
Join Date: May 2012
Posts: 40
Thanks: 1
Thanked 0 Times in 0 Posts
Default statins reduce the risk of heart transplant patients with tumors



The study said that statins reduce the risk of heart transplant patients with tumors


The study found that statin therapy can help heart transplant patients to reduce the HSPE1 risk of tumor development in a very long period of time.Single center after heart transplantation in patients taking statins, study found that the incidence of each cancer is roughly reduced by half.The cumulative rate of cancer incidence in patients with heart failure at the annual meeting, MD GeorgM.Froelich of the University Hospital of Zurich, said after heart transplantation the use of statin therapy within HSPH1 eight years after 13%, without the use of statin therapy cumulative rate of cancer incidence in the postoperative period of eight years to reach 34% (P <0.003).Cohort study of patients taking statins after adjustment for age, gender, cardiomyopathy, immune therapy and cancer survival rate was 67%. Previous studies have shown that statins not only for the treatment of atherosclerosis hardening HTATIP2 effective and also have a role in the overall survival for heart transplant patients.Froelich explained, these data make the benefits of statins extend to the reason of the long-term mortality in patients after heart transplantation immunotherapy on the one hand helps the body fight transplant rejection of the donor heart implanted bring the other in turn can effective against HTRA1 cancer cells.Froelich Research Center study found that from 1985 to 2007 a total of 255 patients in the postoperative survival time of heart transplantation for at least more than one year, while at the same time of the follow-up of 42% of patients the cancer.Has recommended in the guide given to all heart transplant patients with statin use, Froelich also recommended, these results may suggest another reason for the HTRA2 occurrence of cardiac transplantation in patients with cancer,

"L consider these data alone is not sufficient to prove the existence of a true causal relationship between Strasbourg, France, University Hospital, MD GeraldRou" and on MedpageToday, he said, "Obviously, the following conclusions before need more support. But if this conclusion is true, for the treatment of heart transplant patients is a breakthrough through the the Froelich study confirmed the role of statins to reduce the occurrence of cardiac transplantation in patients with tumor very reasonable of. He pointed out that statins has pleiotropic effects, including immune adjustment, the role of cells in the matrix metalloproteinases and cancer occurred and the development of the process of apoptosis. he adds, but whether all of his statin class of drugs for differenttypes of patients, or others, such as lung transplant recipients enough to accept the strict immunosuppressive therapy in patients with this problem, is not clear.They observed data, the benefits of statins will continue for some time. 10 years of follow-up study, statin users were 10 years tumor cumulative incidence rate of the earth 18% without taking statin therapy in patients up to 39%. Patients 12 years of follow-up study, patients taking statin therapy, 10 years, tumor cumulative incidence of 22%, without taking statins and 42% between a statistically significant difference. In previous studies, patients taking statin therapy often showed increased overall survival and better cancer-free survival (P <0.0001) it is evident that cholesterol levels after heart transplantationpatients with statin drugs will make cancer-free survival rate was significantly higher (P <0.0001), and not consider the level of cholesterol, statins after heart transplantation in patients with cancer-free survival increased significant (P = 0.96). Use of statin therapy but can not completely avoid the occurrence of side effects, these side effects including Froelich warning included rhabdomyolysis, research group, said: "These data need long time to come randomized clinical trial to further validate.
Reply With Quote
Reply

Tags
heart , hspe1 , hsph1 , htatip2 , htra1 , htra2 , patients , reduce , risk , statins , transplant , tumors


Thread Tools
Display Modes

Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off
Trackbacks are On
Pingbacks are On
Refbacks are On

Forum Jump

Similar Threads
Thread Thread Starter Forum Replies Last Post
~~~ ASSOCIATION ~~~ lindallalbincochrane@gmail.com Forum Physik 1 02-18-2013 07:21 AM
10 minutes to test your heart is healthy ztracy Biology Forum 7 08-28-2012 06:49 AM
Research News - C. difficile increases risk of death 6-fold in patients with inflamma moleculardude Science News and Views 0 04-21-2011 11:14 AM
effexor xr advertising lipitor heart failure preventing heartproblems while taking geodon freefvideo@gmail.com Protein Forum 0 03-27-2008 12:16 PM
Cosa e' un virus ? G. Paolo Forum Biologia 182 05-29-2006 06:33 PM


All times are GMT. The time now is 02:58 AM.


Powered by vBulletin® Version 3.8.4
Copyright ©2000 - 2014, Jelsoft Enterprises Ltd.
Copyright 2005 - 2012 Molecular Station | All Rights Reserved
Page generated in 0.14638 seconds with 16 queries